Logo image of EPSN

EPSILON ENERGY LTD (EPSN) Stock Fundamental Analysis

USA - NASDAQ:EPSN - CA2943752097 - Common Stock

5.08 USD
-0.12 (-2.31%)
Last: 9/19/2025, 12:24:41 PM
Fundamental Rating

6

Overall EPSN gets a fundamental rating of 6 out of 10. We evaluated EPSN against 210 industry peers in the Oil, Gas & Consumable Fuels industry. EPSN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EPSN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

EPSN had positive earnings in the past year.
EPSN had a positive operating cash flow in the past year.
In the past 5 years EPSN has always been profitable.
Each year in the past 5 years EPSN had a positive operating cash flow.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

EPSN has a Return On Assets of 4.18%. This is comparable to the rest of the industry: EPSN outperforms 57.14% of its industry peers.
EPSN has a Return On Equity of 5.16%. This is comparable to the rest of the industry: EPSN outperforms 43.33% of its industry peers.
The Return On Invested Capital of EPSN (6.85%) is comparable to the rest of the industry.
EPSN had an Average Return On Invested Capital over the past 3 years of 10.21%. This is significantly below the industry average of 21.66%.
Industry RankSector Rank
ROA 4.18%
ROE 5.16%
ROIC 6.85%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

With a decent Profit Margin value of 11.75%, EPSN is doing good in the industry, outperforming 60.95% of the companies in the same industry.
EPSN's Profit Margin has declined in the last couple of years.
EPSN's Operating Margin of 29.48% is fine compared to the rest of the industry. EPSN outperforms 72.38% of its industry peers.
EPSN's Operating Margin has declined in the last couple of years.
EPSN's Gross Margin of 74.34% is amongst the best of the industry. EPSN outperforms 86.67% of its industry peers.
EPSN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.48%
PM (TTM) 11.75%
GM 74.34%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

9

2. Health

2.1 Basic Checks

EPSN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for EPSN has been reduced compared to 1 year ago.
EPSN has less shares outstanding than it did 5 years ago.
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 3.29 indicates that EPSN is not in any danger for bankruptcy at the moment.
EPSN has a Altman-Z score of 3.29. This is amongst the best in the industry. EPSN outperforms 83.33% of its industry peers.
EPSN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.29
ROIC/WACC0.79
WACC8.7%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 2.23 indicates that EPSN has no problem at all paying its short term obligations.
EPSN's Current ratio of 2.23 is fine compared to the rest of the industry. EPSN outperforms 78.10% of its industry peers.
A Quick Ratio of 2.23 indicates that EPSN has no problem at all paying its short term obligations.
EPSN's Quick ratio of 2.23 is fine compared to the rest of the industry. EPSN outperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 2.23
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.00% over the past year.
EPSN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.77% yearly.
EPSN shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.91%.
EPSN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.38% yearly.
EPS 1Y (TTM)68%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%375%
Revenue 1Y (TTM)45.91%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%59.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.10 indicates a correct valuation of EPSN.
Compared to the rest of the industry, the Price/Earnings ratio of EPSN indicates a somewhat cheap valuation: EPSN is cheaper than 66.19% of the companies listed in the same industry.
EPSN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
EPSN is valuated reasonably with a Price/Forward Earnings ratio of 10.38.
EPSN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EPSN is cheaper than 65.24% of the companies in the same industry.
EPSN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 12.1
Fwd PE 10.38
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EPSN is valued cheaply inside the industry as 80.48% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EPSN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 17.91
EV/EBITDA 4.12
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

EPSN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

EPSN has a Yearly Dividend Yield of 4.53%, which is a nice return.
In the last 3 months the price of EPSN has falen by -37.42%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 6.17, EPSN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, EPSN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.53%

5.2 History

EPSN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

EPSN pays out 106.25% of its income as dividend. This is not a sustainable payout ratio.
DP106.25%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

EPSILON ENERGY LTD

NASDAQ:EPSN (9/19/2025, 12:24:41 PM)

5.08

-0.12 (-2.31%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-04 2025-11-04
Inst Owners63.82%
Inst Owner Change17.94%
Ins Owners4.76%
Ins Owner Change0.49%
Market Cap112.06M
Analysts82.86
Price Target8.57 (68.7%)
Short Float %2.16%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 4.53%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP106.25%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-13 2025-06-13 (0.0625)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)79.45%
Min EPS beat(2)26.05%
Max EPS beat(2)132.84%
EPS beat(4)2
Avg EPS beat(4)16.68%
Min EPS beat(4)-50.98%
Max EPS beat(4)132.84%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)15.75%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)35.29%
Revenue beat(4)2
Avg Revenue beat(4)8.04%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)35.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-70%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9.35%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.1
Fwd PE 10.38
P/S 2.55
P/FCF 17.91
P/OCF 4.54
P/B 1.12
P/tB 1.12
EV/EBITDA 4.12
EPS(TTM)0.42
EY8.27%
EPS(NY)0.49
Fwd EY9.64%
FCF(TTM)0.28
FCFY5.58%
OCF(TTM)1.12
OCFY22.03%
SpS2
BVpS4.54
TBVpS4.54
PEG (NY)0.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.18%
ROE 5.16%
ROCE 11.17%
ROIC 6.85%
ROICexc 7.49%
ROICexgc 7.49%
OM 29.48%
PM (TTM) 11.75%
GM 74.34%
FCFM 14.21%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexcg growth 3Y-47.2%
ROICexcg growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 148.22%
Cap/Sales 41.87%
Interest Coverage 491.49
Cash Conversion 97.15%
Profit Quality 120.94%
Current Ratio 2.23
Quick Ratio 2.23
Altman-Z 3.29
F-Score7
WACC8.7%
ROIC/WACC0.79
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%375%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)45.91%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%59.03%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y158.31%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year539.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.93%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%